Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569049 · ClinicalTrials.gov registry record
Molecular Analysis of Breast Cancer
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 788
- Enrollment target
NCT00569049: Completed study, sponsored by Stanford University.
NCT00569049 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 788 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00569049 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 788 participants
- Enrollment target
Study Summary
This is a research-based study that is looking at the biologic features of breast tissue, lymph node tissue, or blood in order to study breast cancer development growth, and spread. Through tissue and/or blood samples we hope to gain further knowledge and understanding of how to improve diagnosis and treatment of breast cancer by identifying the molecular markers that predict clinical outcome and response to therapy.
Interventions
- PROCEDURE breast tissue, lymph node tissue or blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 788 participants |
| Start Date | 1996-05 |
| Est. Completion | 2011-07-01 |
What the finished NCT00569049 record still lists
NCT00569049 is an observational study that tracks outcomes without assigning an intervention. The registered 788 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which breast tissue, lymph node tissue or blood is the first listed.
NCT00569049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00569049 about?
NCT00569049 is a clinical study titled "Molecular Analysis of Breast Cancer". This is a research-based study that is looking at the biologic features of breast tissue, lymph node tissue, or blood in order to study breast cancer development growth, and spread. Through tissue and/or blood samples we hope to gain further knowledge and understanding of how to improve diagnosis an...
What is the current status of trial NCT00569049?
This trial is currently completed. The enrollment target is 788 participants. The study started on 1996-05. Estimated completion is 2011-07-01.
What interventions are being tested in trial NCT00569049?
The interventions under investigation include: breast tissue, lymph node tissue or blood (PROCEDURE).
Who is sponsoring clinical trial NCT00569049?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06488781 · 787 participants · Phase 2
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
- NCT06876649 · 787 participants · Phase 4
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- NCT04967989 · 790 participants · Phase 3
Clarifying the Optimal Application of SLT Therapy Trial
- NCT06162611 · 790 participants · Phase 4
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia